Cargando…
Dupilumab for the treatment of prurigo nodularis: A systematic review
BACKGROUND: Conventional treatment techniques have limited efficacy and more side effects in the treatment of prurigo nodularis. The better alternative treatment option for better outcomes of the disease is dupilumab. OBJECTIVE: The objective of this study was to systematically review dupilumab-rela...
Autores principales: | Cao, Peng, Xu, Wenjing, Jiang, Shuyi, Zhang, Litao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895771/ https://www.ncbi.nlm.nih.gov/pubmed/36742321 http://dx.doi.org/10.3389/fimmu.2023.1092685 |
Ejemplares similares
-
Simultaneous treatment of Samter triad and prurigo nodularis with dupilumab
por: Bloomstein, Joshua D., et al.
Publicado: (2021) -
Recalcitrant prurigo nodularis treated successfully with dupilumab
por: Rambhia, Pooja H., et al.
Publicado: (2019) -
Effective Treatment of Prurigo Nodularis with Dupilumab: A Case Report
por: Liu, Chuan, et al.
Publicado: (2022) -
Resolution of Treatment-Refractory Prurigo Nodularis With Dupilumab: A Case Series
por: Wieser, Jill K, et al.
Publicado: (2020) -
Reactivation of inflammatory monoarthritis during dupilumab treatment used for prurigo nodularis
por: Bostan, Ecem, et al.
Publicado: (2021)